Defilade Capital Management, L.P.
Position in NBIX — Neurocrine Biosciences Inc
CIK 2088557
EMERYVILLE, CA
Position in NBIX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$27,656,441
New position
Shares Held
209,932
first reported quarter
Ownership
0.207%
of shares outstanding
% of Portfolio
3.96%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Defilade Capital Management, L.P. holds $35,982,530 across 2 Drug Manufacturers - Specialty & Generic names.
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,656,441 | 209,932 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||